World of DTC Marketing

JULY 20, 2020

QUICK READ: Pharma digital agencies are doing their clients a huge disservice by recommending heavy paid search. The reality is that the ROI for most paid search is very low. If the growing cost of digital advertising were matched by commensurate sales growth, then higher digital ad spend would pose no problem. But the reality is quite different: While digital spending is becoming more expensive, it is generally not becoming more effective. .

Marketing 148

Marketing Sales Production Research 148

Camargo

JULY 24, 2020

The post Multidisciplinary Team Advances Immuno-Oncology Development appeared first on Camargo.

Development 130

Development 130

Pharma Mirror

JULY 23, 2020

DuPont Nutrition & Biosciences (DuPont) today announced a research collaboration in microbiome science with the Center for Advanced Biotechnology and Medicine (CABM) at Rutgers University in New Jersey. The two-year research partnership will focus on improving the benefit/risk ratio of chemotherapy by decreasing gut inflammation caused by chemotherapy to potentially improve response rates through modulation.

Research 130

Research Medicine 130

Outsourcing Pharma

JULY 22, 2020

A leader from the specialty logistics firm discusses how the clinical researching industry is shifting, thanks in large part to the pandemic, and how to prepare for the future.

Trials 98

Trials Clinical Research Research Contract Manufacturing 98

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

World of DTC Marketing

JULY 21, 2020

QUICK READ : Pharma seems to be making great progress in the use of digital marketing to reach HCP’s but when it comes to consumers they still rate near the bottom. Not only does pharma spend too much on paid media, without adequate measurement, but they also don’t invest enough in their product website development and testing. Attention on the Internet is at a premium, even for online health seekers.

Branding 131

Branding Marketing Production Development 131

Camargo

JULY 23, 2020

The post Multidisciplinary Team Advances Immuno-Oncology Development appeared first on Camargo.

Development 130

Development 130

Syntegon Technology Pharma Blog

JULY 23, 2020

88

88

World of DTC Marketing

JULY 22, 2020

QUICK READ : The government is agreeing to pay billions of dollars to the first company that developed a COVID-19 vaccine. We would like to think that any vaccine development will be within GMP and the drug approval process guidelines but when billions of dollars are at stake will the industry cut corners and who is going to be the watchdog? U.S. health officials agreed to pay $1.95 billion for 100 million doses of a vaccine made by Pfizer Inc. and BioNTech SE, the latest step in an effort to fi

Vaccination 130

Vaccination Vaccine Pharma Companies Development 130

Outsourcing Pharma

JULY 22, 2020

The company has expanded the footprint of the location to accommodate an anticipated increase in the need for COVID-19 vaccine and storage needs.

Vaccination 86

Vaccination Vaccine Clinical Development Development 86

Intouch Solutions

JULY 22, 2020

Last week, Fierce Life Sciences hosted a free, three-day virtual version of Digital Pharma Week. Check out some of the key takeaways here. The post Top Takeaways From Digital Pharma Week appeared first on Intouch Solutions.

Life Science 80

Life Science Marketing 80

Advertisement

Clinical Supply

JAMA Internal Medicine

JULY 20, 2020

This cross-sectional study estimates the prevalence of severe acute respiratory syndrome coronavirus 2 antibodies in convenience samples from 10 geographic sites in the United States.

Antibody 76

Antibody 76

World of DTC Marketing

JULY 23, 2020

QUICK READ : Prescribers are reviewing some of their favorite prescribed drugs and are open to learning about new drugs in terms of efficacy and patient outcomes but you had better be ready to talk about patients beyond the science. Some may think it’s a bad time to be launching a drug but actually the reverse may be true. Doctors who don’t work in hospitals have the time to engage with drug MLS people virtually and a lot of them are reviewing the drugs that “they tend to presc

Drugs 130

Drugs Production Marketing Branding 130

BioPharma Reporter

JULY 22, 2020

US government agrees a deal for 100m doses of potential vaccine, with option to take further 500m order.

Vaccination 71

Vaccination Vaccine Regulation Marketing 71

Outsourcing Pharma

JULY 23, 2020

The CRO has been tapped by the Frederick National Laboratory for Cancer Research to provide clinical services for an ongoing COVID-19 study.

Trials 62

Trials Research Clinical Development Development 62

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

JAMA Internal Medicine

JULY 19, 2020

This essay describes the author’s adaptations to dystopian changes in hospital procedures and the reverberations throughout her life brought on by the COVID-19 pandemic.

75

75

Delveinsight

JULY 23, 2020

The current Familial chylomicronemia syndrome market is mainly dominated by traditional TG-lowering agents, and as per DelveInsight analysis, the market worth was estimated to be USD 1.0 million in 2017. A rare autosomal recessive disorder, Familial chylomicronemia syndrome (FCS) affects 1 in 1 to 2 million people ( Burnett and Hegele, 1999; Pouwels et al. 2008 ).

Marketing 61

Marketing Gene Therapy Drugs Genome 61

BioPharma Reporter

JULY 22, 2020

A report by IDA outlines investment made by biopharma into cell and gene development and manufacturing capabilities.

Gene 61

Gene Manufacturing Development 61

Druggist

JULY 20, 2020

Evorel patches have been subject to shortages since 2019. Today the stock of Evorel patches, including Evorel Conti and Evorel Sequi is being replenished with improved availability in many pharmacies due to imposed supply restrictions by the wholesaler which redistributes Evorel products. Today I am looking at different options for treatment of Hormone Replacement Therapy (HRT), focusing on Evorel, Evorel Conti and Evorel Sequi alternative drugs.

Pharmacy 59

Pharmacy Drugs Containment Production 59

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

JAMA Internal Medicine

JULY 19, 2020

This randomized withdrawal trial evaluates whether discontinuing nonsteroidal anti-inflammatory drugs and engaging in a telephone-based cognitive behavioral therapy program is noninferior to continuing nonsteroidal anti-inflammatory drugs for patients with knee osteoarthritis.

Drugs 73

Drugs Trials 73

Delveinsight

JULY 22, 2020

The technology over the past few years has opened many new avenues and possibilities that have radically transformed the healthcare industry’s outlook. Today the tech-based healthcare industry is providing many unique solutions to the patient’s care which are more efficient and effective than the traditional services. The method of services delivery and design has transformed to the extent that people can access healthcare services from thousands of miles away with just a smartphone.

Doctor 59

Doctor Doctors Marketing Production 59

Drug Channels

JULY 24, 2020

Today’s guest post comes from Frank Dana, Chief Commercial Officer at ConnectiveRx. Frank discusses how the loss of commercial insurance coverage will affect the newly unemployed. He describes how ConnectiveRx's affordability tools can help pharmaceutical manufacturers and patients. To learn more, download ConnectiveRx’s free reference: Five Keys to Building a Successful Copay Strategy in the COVID-19 Era.

Manufacturing 52

Manufacturing Drugs 52

Pharma Focus Asia

JULY 24, 2020

When dealing with teenage issues, it’s often not as easy as simply getting on with it. With most issues arising during teenage years, tailored support and methods to overcome issues are very much needed, whether medically or holistically. Here are six options for teenagers looking to overcome any problems. Speak with a Doctor In the […].

Doctors 52

Doctors Doctor 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

Clinical Research

JAMA Internal Medicine

JULY 19, 2020

This analysis compares reported deaths from COVID-19, February 23 to April 4, 2020, and total mortality in Italy from January 12 through April 4 in the years 2015 through 2020.

70

70

Delveinsight

JULY 23, 2020

Olema Oncology raises USD 54 Million for breast cancer program. Olema Oncology has raised USD 54 million to push its lead program into the clinic and boost its R&D efforts in other areas. The capital will bankroll a phase 1/2 study of the asset, OP-1250, as a single agent. Olema Oncology will assess the drug, a complete estrogen receptor antagonist, in patients with ER-positive, HER2-negative breast cancers that have come back despite other treatments or that have spread locally or to other

Protein 52

Protein Bacteria Scientist Research 52

Drug Channels

JULY 23, 2020

The stunning growth of specialty pharmacies in the 340B Drug Pricing Program has accelerated a troubling trend: Patients covered by commercial insurance and Medicare Part D are footing the bill for 340B savings. That's the uncomfortable reality of the 340B program’s hidden prescription economics. Whenever a prescription is eligible for 340B pricing, an insured patient could pay thousands of dollars out of pocket—even as the 340B hospital and its contract pharmacy generate substantial profits

Pharmacy 52

Pharmacy Branding Drugs 52

Triage Cancer

JULY 23, 2020

The Latest Information About Unemployment Insurance Benefits. More than 40 million people have lost their jobs since March of this year, due to the economic havoc brought by the COVID-19 pandemic. If you find yourself in the position where you have lost your job, you may be eligible for unemployment benefits. Unemployment benefits are a form of insurance payout.

52

52

Advertisement

Clinical Supply

JAMA Internal Medicine

JULY 19, 2020

This randomized clinical trial assesses the use of a shared decision-making tool during clinical encounters and the effects on anticoagulant treatment decisions in patients with atrial fibrillation who are at risk of experiencing stroke.

Clinical Trials 59

Clinical Trials Clinical Trials Trials 59

Clinical Trial Gurus

JULY 24, 2020

Identifying queries is a complicated task that requires a high level of training and critical thinking. Monitors must be able to look through source documents, EDC platforms, and vendor information to identify irregularities. It is important that monitors identify all inconsistencies especially in cases where patient safety may be affected.

Clinical Research 52

Clinical Research Research 52

BioPharma Reporter

JULY 23, 2020

Gilead buys a stake in Tizona for its cancer immunotherapies, whilst holding the option to buy outright.

Regulation 52

Regulation Marketing 52

Forte Research Systems®

JULY 23, 2020

Providing interim HRPP support can help your team fill in staffing gaps while staying on top of research and moving protocols forward.

Research 52

Research 52

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials